TET2 mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemia

Haematologica. 2023 Nov 1;108(11):3135-3141. doi: 10.3324/haematol.2022.282528.
No abstract available

Publication types

  • Letter

MeSH terms

  • DNA-Binding Proteins / genetics
  • Dioxygenases*
  • Humans
  • Leukemia, Myelomonocytic, Chronic* / genetics
  • Mutation
  • Myelodysplastic Syndromes* / genetics

Substances

  • TET2 protein, human
  • DNA-Binding Proteins
  • Dioxygenases